Tuesday, July 29, 2014
EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology
EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules announces expansion of its pharmaceutical development implementing its sub-micron platform technology.
http://bit.ly/1mYOhK7
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment